SCHEMBL20064280

SCHEMBL20064280

Fc1cnc2c(OC3CCC3)cccc2c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.48
GRM5 P41594 3/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
HTR1A P08908 2/20 0.38
HPGDS O60760 1/20 0.37
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
TNIK Q9UKE5 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NMT1 P30419 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20064279 0.83 KDM4E (0.49) MCHR1JAK2JAK1TYK2JAK3
SCHEMBL21222061 0.79 ENPP2 (0.38) HPGDS
SCHEMBL20064263 0.79 ENPP2 (0.38) HPGDS
SCHEMBL9050436 0.77 MCHR1 (0.57) MCHR1KDM4EMEN1NPC1RAB9A
SCHEMBL20064274 0.76 HPGDS (0.43) GRM5JAK2JAK1TYK2JAK3
Hydrochloric Acid SCHEMBL9051831 0.76 MCHR1 (0.56) MCHR1KDM4EMEN1NPC1RAB9A
SCHEMBL23858507 0.75 HPGDS (0.60) MCHR1HTR1AHPGDSKDM4EMEN1
SCHEMBL30081475 0.75 HPGDS (0.60) MCHR1HTR1AHPGDSKDM4EMEN1
SCHEMBL4887893 0.74 MCHR1 (0.61) MCHR1KDM4EMEN1NPC1RAB9A
SCHEMBL3717235 0.74 JAK2 (0.50) MCHR1JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069863-A1 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-19 WO disclosed